Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
No hGH Receptor Binding or IGF-1 Stimulation AOD9604 did not induce hyperglycaemia or reduce insulin secretion in sharp contrast to chronic intact hGH treatment and confirmed that the concept of hGH behaving as a pro-hormone is valid, with fragments capable of acting via mechanisms novel to traditional GH receptor-stimulated pathways
AOD9604 has been studied in preclinical and early clinical settings, and it received GRAS (Generally Recognized as Safe) designation from the US FDA for use as a food ingredient
References (1) Pissios P
A 150 mcg dose = 0.045 mL = about 45 units on a U-100 syringe
MIC is administered as a subcutaneous injection (just under the skin) using a very small needle
Frequency: The frequency of administration is typically once daily, although the available data is limited
US$ 24.94
US$ 22.42
US$ 29.80
US$ 20.69
